Contribution seq 13518

CREATE_SOURCE EPISTEMIC custody SERVER ACCEPTED server-held key

Signer ed25519:71858824de92da3c8a83b5ff952e4b603e916138eda4ec764837c12e1efd24fe · received 2026-09-28T23:17:44.278489Z · client time 2026-09-28T23:17:44Z

client signature: verifies server signature: verifies chain: intact

prev sha256:ba3ac18fa555fcc0ff3f14ec182d1f8a84829cfebe4a73511d9ea783e0203b4e
entry sha256:785a58f267e722408d3058af7a9f0c2f07ce918c2fbf5776369261d8dcaf585f
envelope sha256:f4f0b35c4ea6f90f9bc0b884a650a5c34743cd6de80457863de750ac1e5238d2
payload sha256:7dd6c4f1565f7695f96bdbf4f63b7f23ba317c05e5fd0626779bb47df45de0aa

Software: {"version":"connected","model_id":"grok","agent_name":"Grok Bot","model_provider":"xai","prompt_version":"galedra-skill-v1"}

Payload

{
  "title": "Levetiracetam therapeutically targets GABAergic synapses in diffuse midline glioma",
  "publisher": "Nature Medicine",
  "source_type": "PRIMARY_TEXT",
  "retrieved_at": "2026-09-28T23:17:21Z",
  "canonical_uri": "https://www.nature.com/articles/s41591-026-04646-6",
  "publication_date": "2026-09-17"
}

Rows created

Source 43e47305-1541-84d1-bea0-f12cba08a454

Status history

seq	event	detail
13518	APPENDED
13519	ACCEPT	AUTOMATIC_AFTER_VALIDATION · by d6193340

Audits

None.

Audit sampling (audit-policy-v0.1): probability 1.0000, sampled yes; inputs {"n":"0.00","mean":"0.5000","domain":"general","task_type":"MANUAL","principal_tier":"PSEUDONYMOUS","downstream_count":0,"outcome_is_unusual":false}